According to the latest report by IMARC Group, titled "Collagen Market Report by Source (Bovine, Porcine, Poultry, Marine, and Others), Product (Gelatin, Hydrolyzed Collagen, Native Collagen, Synthetic Collagen, and Others), Application (Food and Beverages, Healthcare, Cosmetics, and Others), and Region 2024-2032," the global collagen market size reached US$ 10.0 Billion in 2023. Collagen is a tough, insoluble, fibrous protein found in the extracellular matrix and several tissues throughout the body. It is synthesized from amino acids like proline, glycine, and hydroxyproline, which form protein fibrils in a triple-helix scaffold. Collagen provides structure, support, strength, and elasticity to human skin, muscles, bones, and connective tissues. It also offers numerous health benefits, such as preventing bone loss, relieving joint pain, boosting muscle mass, promoting brain health, improving hair and nail growth, and enhancing skin strength and elasticity. As a result, collagen is extensively used as an essential ingredient in producing a wide range of cosmetics and personal care products. Besides this, it is employed to manufacture flowable scaffolds, nerve tubes, ophthalmic shields, bone graft substitutes, vascular closure devices, dental membranes, and plugs.
Global Collagen Market Trends:
Increasing prevalence of chronic disorders, such as scurvy, Stickler, Marfan, Alport, Ehlers-Danlos, osteogenesis imperfecta, systemic sclerosis or lupus erythematosus, oral submucous fibrosis, and epidermolysis bullosa, caused by the degradation of collagen is primarily driving the market growth. Moreover, collagen synthesis in the body slows down with age and increased consumption of alcohol and tobacco products, resulting in skin sagging, breakdown, wrinkles, and aging. This, in turn, is fuelling the demand for collagen-based supplements, thus aiding in market expansion. Besides this, extensive product utilization across various cosmetic and personal care products to hydrate skin and reduce wrinkles on account of its skin rejuvenation and beauty enhancement properties are creating a positive outlook for the market. Furthermore, innovative advancements, such as the development of recombinant collagen technologies and widespread product utilization in tissue engineering, due to its association with cell interaction, migration, attachment, differentiation, and organization, are contributing to the market growth. In addition to this, the largescale product utilization across the food and beverage (F&B) sector in producing numerous confectionery items to enhance their chewiness, foam stability, and texture is presenting remunerative opportunities for the market. Looking forward, the market value is projected to reach US$ 16.9 Billion by 2032, expanding at a CAGR of 5.8% during 2024-2032.
Market Summary:
- Based on the source, the market is segregated into bovine, porcine, poultry, marine, and others.
- On the basis of the product, the market has been categorized into gelatin, hydrolyzed collagen, native collagen, synthetic collagen, and others.
- Based on the application, the market has been divided into food and beverages (functional food, functional beverages, dietary supplements, confectionery, desserts, and meat processing), healthcare (bone and joint health supplements, wound dressing, tissue regeneration, medical implants, cardiology, and drug delivery), cosmetics (beauty supplements [nutricosmetics] and topical cosmetic products), and others.
- On a regional basis, the market has been segmented into North America (the United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.
- The competitive landscape of the market has also been examined, with some of the key players being Advanced BioMatrix Inc., Collagen Solutions Plc (Rosen's Diversified Inc.), Connoils LLC, Croda International Plc, Gelita AG, Gelnex, ITALGELATINE S.p.A., Koninklijke DSM N.V., Lapi Gelatine S.p.a. , Nippi Collagen NA Inc. (Nippi Inc), Nitta Gelatin NA Inc., Rousselot (Darling Ingredients) and Tessenderlo Group.
Report Coverage:
Report Features |
Details |
Base Year of the Analysis |
2023 |
Historical Period |
2018-2023 |
Forecast Period |
2024-2032 |
Units |
US$ Billion |
Segment Coverage |
Source, Product, Application, Region |
Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered |
Advanced BioMatrix Inc., Collagen Solutions Plc (Rosen's Diversified Inc.), Connoils LLC, Croda International Plc, Gelita AG, Gelnex, ITALGELATINE S.p.A., Koninklijke DSM N.V., Lapi Gelatine S.p.a. , Nippi Collagen NA Inc. (Nippi Inc), Nitta Gelatin NA Inc., Rousselot (Darling Ingredients) and Tessenderlo Group |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N A
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800